Opioid Therapy Practice and Policy Issues National Opioid Pain Care Agreement and Large Quantity Opi - PowerPoint PPT Presentation

1 / 13
About This Presentation
Title:

Opioid Therapy Practice and Policy Issues National Opioid Pain Care Agreement and Large Quantity Opi

Description:

and Large Quantity Opioid Prescription Review. Francine Goodman, Pharm.D., BCPS. Clinical Pharmacy Specialist, National PBM Services ... – PowerPoint PPT presentation

Number of Views:207
Avg rating:3.0/5.0
Slides: 14
Provided by: fg655
Category:

less

Transcript and Presenter's Notes

Title: Opioid Therapy Practice and Policy Issues National Opioid Pain Care Agreement and Large Quantity Opi


1
Opioid Therapy Practiceand Policy
IssuesNational Opioid Pain Care Agreementand
Large Quantity Opioid Prescription Review
  • Francine Goodman, Pharm.D., BCPS
  • Clinical Pharmacy Specialist, National PBM
    Services
  • Project Leader, National Opioid Pain Care
    Agreement

2
National Opioid Pain Care AgreementThree
Documents
  • DIRECTIVE
  • Supports
  • a standard, national Opioid Pain Care Agreement
  • a single location (Clinical Warnings / CWAD) in
    VHAs Computerized Patient Record System (CPRS)
  • THE OPCA
  • Available via iMedConsentTM program
  • PATIENT INFORMATION
  • Supplements the OPCA

3
TO DO LIST
  • Form work group
  • Obtain field input
  • Combine opioid agreements
  • Distill core OPCA

4
TO DO LIST
  • Improve readability
  • Pilot in patients
  • Build consensus (ongoing)

5
FINAL TO DOS
  • (FY10)
  • Submit to VACO for concurrence
  • Post Model OPCA on VHA Pain Management Web
    sitehttp//www1.va.gov/pain_management/index.cfm
  • Provider Education

STILL UNDER CONSTRUCTION
THANK YOU FOR YOUR PATIENCE
6
Large Quantity Opioid Rx Reviews
  • Goal
  • To evaluate appropriateness (quality and safety)
    of aberrant large-quantity opioid prescriptions
  • Extends Multi-site and Multi-VISN Opioid / CN101
    Rx Reviews

7
CN101 Large Quantity Rx Reviews
  • National PBM identifies Large Quantity cases that
    are considered for Protected Peer Review
  • Started June 2009

8
Methods
  • Identify Top 10 Large Quantity patients in each
    VISN
  • 10 or fewer cases per VISN per formulation
  • Up to 30 cases possible per VISN
  • Includes multi-VISN fills
  • Probably represents top 0.05 or less of all
    CN101 patients

9
Cutoffs
  • Intended to reduce size of database
  • Tab/cap gt 1200 / 3 mo
  • Patches gt 90 / 3 mo
  • Oral Liquid gt 6000 / 3 mo

10
Process for Large Quantity Cases
PBM
Protected Peer Review Process 1)
Multidisciplinary Peer Cmte screen
CMOs COSs COPs
VPEs
Re-evaluation of opioid care plan
PPR Process 2) PPR of selected cases
11
Accountability
  • PBM requires no follow-up not involved in PPRs
  • Multidisciplinary Peer Cmtes should ensure timely
    feedback to providers to ensure patient and
    public safety
  • Quality Measure
  • CN101 utilization by Large Quantity patients
    (q6mo)
  • National roll-up of PPRs
  • Process Evaluation Dec 2009

12
Reference Guide for PPRs
  • Guides reviewers to potentially important aspects
    of care
  • Available through VPEs and CMOs
  • 1 Choice of diagnostic tests and timely ordering
    of those diagnostic tests.
  • 2 Performance of a procedure and / or treatment
  • 3 Addressing abnormal results of diagnostic tests
  • 4 Timeliness of diagnosis and appropriateness of
    diagnosis    
  • 5 Timing of treatment initiation and
    appropriateness of treatment
  • 6 Adequacy of technique during procedures
  • 7 Recognition and communication of critical clues
    to patient's condition during the period of
    clinical deterioration
  • 8 Timely initiation of appropriate actions during
    periods of clinical deterioration
  • 9 Medical record documentation
  • 10 Supervision of health profession trainees
  • 11 Other relevant aspects of care

13
Questions?
Write a Comment
User Comments (0)
About PowerShow.com